Jiangsu Hengrui Medicine (600276.SS) Price-to-Earnings (P/E) Ratio
Price: $49.97
Market Cap: $317.28B
Avg Volume: 48.75M
Market Cap: $317.28B
Avg Volume: 48.75M
Country: CN
Industry: Drug Manufacturers - General
Sector: Healthcare
Industry: Drug Manufacturers - General
Sector: Healthcare
Price-to-Earnings (P/E) Ratio Summary
Jiangsu Hengrui Medicine 's P/E ratios across different time periods:
- TTM: 45.63
- Annual: 45.90
- Quarterly: 41.00
What is P/E Ratio?
The Price-to-Earnings (P/E) ratio is a valuation metric that compares a company's stock price to its earnings per share (EPS). It indicates how much investors are willing to pay for each dollar of company earnings.
Related Metrics
- Price-to-Book (P/B) Ratio: 6.39
- Price-to-Sales (P/S) Ratio: 10.39
Annual Ratios
Jiangsu Hengrui Medicine Historical P/E Ratio
Historical P/B Ratio
Historical P/S Ratio
TTM P/E Ratio
45.63
P/B Ratio (Annual)
6.39
P/S Ratio (Annual)
10.39
Jiangsu Hengrui Medicine Historical Valuation Metrics
The table below shows various valuation metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | P/E Ratio | P/B Ratio | P/S Ratio |
|---|---|---|---|
| 2024 | 45.90 | 6.39 | 10.39 |
| 2023 | 66.51 | 7.07 | 12.54 |
| 2022 | 62.80 | 6.49 | 11.53 |
| 2021 | 71.42 | 9.24 | 12.49 |
| 2020 | 93.29 | 19.35 | 21.29 |
| 2019 | 72.29 | 15.55 | 16.54 |
| 2018 | 47.97 | 9.89 | 11.20 |
| 2017 | 49.84 | 10.43 | 11.59 |
| 2016 | 34.35 | 7.18 | 8.02 |
| 2015 | 36.83 | 8.05 | 8.58 |
| 2014 | 25.74 | 4.92 | 5.24 |
| 2013 | 29.05 | 5.66 | 5.80 |
| 2012 | 24.06 | 4.97 | 4.77 |
| 2011 | 26.27 | 5.45 | 5.06 |
| 2010 | 42.68 | 9.12 | 8.26 |
Related Metrics
Explore detailed financial metrics and analysis for 600276.SS.